If the Nats can make the NLCS without Bryce Harper, surely Washington can pass drug pricing reform by the end of the year.
The drug lobby is throwing mounds of cash around in an attempt to convince lawmakers that drug pricing’s status quo should remain. Voters disagree!
TL;DR of PhRMA's statement on the House plan to lower drug prices? "We're good with the high prices, thanks."
A leaked draft of a House plan to empower the U.S. government to negotiate drug prices injects enthusiasm into the drug pricing debate and overlaps with President Trump’s plan.
Taxpayer negotiation is a linchpin that will lower drug prices; it’s time for bipartisan action on voters’ top priority.
According to Gallup’s annual review of US public opinion, pharma is the lowest-rated industry in America. That's a new low.
Pharma is siphoning hourly wages from the pockets of hard-working Americans.
Fact Check on Big Pharma’s Attacks on the Administration’s Proposed Part B Reforms.
A judge said HHS can’t make Big Pharma put its list prices in TV ads. HHS is pushing back.
The public needs more protection from Big Pharma profiteering off of billions in taxpayer funded drug research.
Young adults living with diabetes are rationing insulin and dying when they age out of their parents’ insurance plans.
We want patients to buy prescriptions at reasonable prices, but we can’t rely on our northern neighbor forever.
Campaign Relaunches in Light of Recent Setbacks For Administration Blueprint
Americans wanted to list drug price ads on TV. Big Pharma and a federal judge said no.
"More than 3,400 drugs have boosted their prices in the first six months of 2019, an increase of 17% in the number of drug hikes from a year earlier."
Sneaky pharma tactics are keeping lifesaving generic drugs out of reach for patients who need them most.
So many bipartisan drug pricing proposals, so little time.
The US pays two to three times more than other developed nations for prescription drugs.
The DOJ wants a jury trial for Mallinckrodt, the company at the heart of a 97,000 percent price spike for a gel mainly used to treat infant seizures.
The Senate would give the state’s Health Policy Commission authority to demand information from drug companies that have failed to reach a negotiated price with the state secretary of health and human services.